Kbc Group Nv Adma Biologics, Inc. Transaction History
Kbc Group Nv
- $36.3 Billion
- Q4 2024
A detailed history of Kbc Group Nv transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Kbc Group Nv holds 10,063 shares of ADMA stock, worth $169,762. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,063
Previous 6,550
53.63%
Holding current value
$169,762
Previous $131,000
32.06%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ADMA
# of Institutions
326Shares Held
190MCall Options Held
917KPut Options Held
91.6K-
Black Rock Inc. New York, NY18.6MShares$315 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$306 Million0.01% of portfolio
-
State Street Corp Boston, MA13MShares$219 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.6MShares$213 Million0.05% of portfolio
-
Morgan Stanley New York, NY8.6MShares$145 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.31B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...